1. Home
  2. ALZN vs MOB Comparison

ALZN vs MOB Comparison

Compare ALZN & MOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALZN
  • MOB
  • Stock Information
  • Founded
  • ALZN 2016
  • MOB 2008
  • Country
  • ALZN United States
  • MOB Israel
  • Employees
  • ALZN N/A
  • MOB N/A
  • Industry
  • ALZN Medicinal Chemicals and Botanical Products
  • MOB Real Estate Investment Trusts
  • Sector
  • ALZN Health Care
  • MOB Real Estate
  • Exchange
  • ALZN Nasdaq
  • MOB Nasdaq
  • Market Cap
  • ALZN 6.9M
  • MOB 7.2M
  • IPO Year
  • ALZN 2021
  • MOB 2022
  • Fundamental
  • Price
  • ALZN $1.66
  • MOB $1.10
  • Analyst Decision
  • ALZN
  • MOB
  • Analyst Count
  • ALZN 0
  • MOB 0
  • Target Price
  • ALZN N/A
  • MOB N/A
  • AVG Volume (30 Days)
  • ALZN 271.9K
  • MOB 67.2K
  • Earning Date
  • ALZN 09-11-2024
  • MOB 09-09-2024
  • Dividend Yield
  • ALZN N/A
  • MOB N/A
  • EPS Growth
  • ALZN N/A
  • MOB N/A
  • EPS
  • ALZN N/A
  • MOB N/A
  • Revenue
  • ALZN N/A
  • MOB $3,464,353.00
  • Revenue This Year
  • ALZN N/A
  • MOB N/A
  • Revenue Next Year
  • ALZN N/A
  • MOB N/A
  • P/E Ratio
  • ALZN N/A
  • MOB N/A
  • Revenue Growth
  • ALZN N/A
  • MOB 169.70
  • 52 Week Low
  • ALZN $1.40
  • MOB $0.71
  • 52 Week High
  • ALZN $34.50
  • MOB $2.23
  • Technical
  • Relative Strength Index (RSI)
  • ALZN 39.08
  • MOB 56.45
  • Support Level
  • ALZN $1.55
  • MOB $1.03
  • Resistance Level
  • ALZN $1.68
  • MOB $1.20
  • Average True Range (ATR)
  • ALZN 0.14
  • MOB 0.07
  • MACD
  • ALZN 0.05
  • MOB 0.00
  • Stochastic Oscillator
  • ALZN 60.47
  • MOB 50.25

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

About MOB Mobilicom Limited

Mobilicom Ltd is a provider of cybersecurity and smart solutions for drones, robotics & autonomous platforms. As a high-tech company, it designs, develops, and delivers smart solutions targeting global drone, robotics, and autonomous system manufacturers.

Share on Social Networks: